Highland Capital Management (Texas)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-210,600
Closed -$8.98M 285
2016
Q4
$8.98M Sell
210,600
-2,040
-1% -$86.7K 0.42% 64
2016
Q3
$10.1M Buy
212,640
+88,140
+71% +$4.4M 0.31% 68
2016
Q2
$6.29M Sell
124,500
-91,247
-42% -$4.61M 0.26% 103
2016
Q1
$10.4M Buy
215,747
+138,191
+178% +$5.33M 0.46% 60
2015
Q4
$3.05M Buy
+77,556
New +$3.1M 0.1% 154

Other funds holding AMED

Highland Capital Management (Texas)'s AMED Position: Q1 2017 in Review

Highland Capital Management (Texas) sold out of Amedisys (AMED) in Q1 2017, closing a stake of 210,600 shares — an estimated $8.98M sold.

Highland Capital Management (Texas) first reported a position in AMED in Q4 2015 and held it in 5 quarters. The position peaked at $10.4M in Q1 2016. 152 funds tracked by Wall St. Rank hold AMED as of Q1 2017.

  • Highland Capital Management (Texas) reported no remaining Amedisys position as of Q1 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 210,600 Amedisys shares in Q1 2017, an estimated $8.98M.
  • Highland Capital Management (Texas) first reported a position in Amedisys in Q4 2015 and held it in 5 quarters.
  • Highland Capital Management (Texas)'s Amedisys position peaked at $10.4M in Q1 2016.
  • 152 funds tracked by Wall St. Rank held Amedisys as of Q1 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2017, filed 15 May 2017.